SCHEMBL186125

SCHEMBL186125

CCOc1ncc(OC(=O)O)cn1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
ACACB O00763 3/20 0.38
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
PARP10 Q53GL7 1/20 0.35
PLA2G4B P0C869 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
GLA P06280 1/20 0.34
MAPK1 P28482 1/20 0.33
P4HTM Q9NXG6 1/20 0.33
NPC1 O15118 1/20 0.33
PLK1 P53350 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9852820 0.85 KMT2A (0.40) KMT2ALMNAMAPTNPSR1CCNC
SCHEMBL7020112 0.81 ALDH1A1 (0.33) GLAP4HTM
SCHEMBL185429 0.80 ALDH1A1 (0.40) KMT2ALMNANPSR1GLANPC1
SCHEMBL186657 0.78 KMT2A (0.34) KMT2ALMNAMAPTNPSR1CCNC
SCHEMBL3819124 0.77 NQO1 (0.50) KMT2AMAPTPARP10NPC1
SCHEMBL186124 0.76 MAPT (0.59) MAPTPLA2G4BCYP2C9CYP2C19P4HTM
SCHEMBL185620 0.75 LMNA (0.35) KMT2ALMNAMAPTCYP2C9CYP2C19
SCHEMBL186360 0.74 VNN1 (0.40) KMT2AACACBCYP2C19L3MBTL1GLA
SCHEMBL7166940 0.74 NQO1 (0.61) KMT2ALMNANPSR1PARP10PLA2G4B
SCHEMBL185449 0.73 ALDH1A1 (0.33) GLAP4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed